Open access in silico tools to predict the ADMET profiling of drug candidates

Expert Opin Drug Discov. 2020 Dec;15(12):1473-1487. doi: 10.1080/17460441.2020.1798926. Epub 2020 Jul 31.

Abstract

Introduction: We are in an era of bioinformatics and cheminformatics where we can predict data in the fields of medicine, the environment, engineering and public health. Approaches with open access in silico tools have revolutionized disease management due to early prediction of the absorption, distribution, metabolism, excretion, and toxicity (ADMET) profiles of the chemically designed and eco-friendly next-generation drugs.

Areas covered: This review meticulously encompasses the fundamental functions of open access in silico prediction tools (webservers and standalone software) and advocates their use in drug discovery research for the safety and reliability of any candidate-drug. This review also aims to help support new researchers in the field of drug design.

Expert opinion: The choice of in silico tools is critically important for drug discovery and the accuracy of ADMET prediction. The accuracy largely depends on the types of dataset, the algorithm used, the quality of the model, the available endpoints for prediction, and user requirement. The key is to use multiple in silico tools for predictions and comparing the results, followed by the identification of the most probable prediction.

Keywords: in silico; ADMET; drug; open access; prediction.

Publication types

  • Research Support, U.S. Gov't, Non-P.H.S.
  • Review

MeSH terms

  • Access to Information
  • Animals
  • Cheminformatics
  • Computational Biology
  • Computer Simulation*
  • Drug Design*
  • Drug Discovery / methods*
  • Drug-Related Side Effects and Adverse Reactions
  • Humans
  • Pharmacokinetics
  • Reproducibility of Results